Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

Diabetes

DPP-4 inhibitors have no mortality benefit in type 2 diabetes, analysis shows

Research has shown that for patients with type 2 diabetes, SGLT-2 inhibitors and GLP-1 agonists were significantly associated with lower rates of death from all causes, compared with both controls and DPP-4 inhibitors.

Dipeptidyl peptidase-4 (DPP-4) inhibitors do not lower death rates in patients with type 2 diabetes, an analysis comparing them with other common treatments has shown[1].

Researchers carried out a network meta-analysis of 236 trials, including 176,310 participants who were treated with DPP-4 inhibitors, glucagon-like peptide 1 (GLP-1) agonists, and sodium-glucose cotransporter-2 (SGLT-2) inhibitors.

The results, published in JAMA (17 April 2018), showed that SGLT-2 inhibitors and GLP-1 agonists were significantly associated with lower all-cause death rates compared with controls (hazard ratio [HR]: 0.80 and 0.88, respectively) and DPP-4 inhibitors (HR: 0.78 and 0.86, respectively). DPP-4 inhibitors were not associated with lower death rates than controls (HR: 1.02).

Incretin-based therapies have been shown in previous studies to improve glycaemic control in people with type 2 diabetes, but the authors of this analysis concluded: “Use of DPP-4 inhibitors was not associated with lower mortality than placebo or no treatment.”

Citation: Clinical Pharmacist DOI: 10.1211/CP.2018.20204905

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Supplementary images

  • Senior woman taking pin-prick blood test

Jobs you might like

See more jobs

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.